The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 7, 2013, Pages 1577-1586

  Moise, Leonard ^a,b   Gutierrez, Andres H ^a   Bailey Kellogg, Chris ^c   Terry, Frances ^b   Leng, Qibin ^d   Abdel Hady, Karim M ^e   VerBerkmoes, Nathan C ^f   Sztein, Marcelo B ^g   Losikoff, Phyllis T ^h   Martin, William D ^b   Rothman, Alan L ^a   De Groot, Anne S ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b EpiVax Inc   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

^e AMERICAN UNIVERSITY IN CAIRO   (Egypt)

^f NEW ENGLAND BIOLABS   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

Agretope; Computational immunology; Cross reactivity; Epitope; Immunodominance; Immunoinformatics; Regulatory T cell; T cell epitope; T cell receptor; TCR; Vaccine

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; CONFERENCE PAPER; CROSS REACTION; DENGUE; EFFECTOR CELL; EPITOPE MAPPING; GENETIC ALGORITHM; GENETIC CONSERVATION; HAND FOOT AND MOUTH DISEASE; HEPATITIS C; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFLUENZA; JANUSMATRIX; MEDICAL INFORMATICS; PHENOTYPE; PREDICTION; REGULATORY T LYMPHOCYTE; SEQUENCE DATABASE;

AGRETOPE; COMPUTATIONAL IMMUNOLOGY; CROSS-REACTIVITY; EPITOPE; IMMUNODOMINANCE; IMMUNOINFORMATICS; REGULATORY T CELL; T CELL EPITOPE; T CELL RECEPTOR; TCR; VACCINE;

ANTIGENS, VIRAL; COMPUTATIONAL BIOLOGY; CROSS REACTIONS; ENTEROVIRUS A, HUMAN; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; RECEPTORS, ANTIGEN, T-CELL;

EID: 84880911013     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24615     Document Type: Conference Paper

References (62)

1. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012; 287:1168-77; PMID:22102287; http://dx.doi.org/10.1074/jbc.M111.289488.
2. Kersh GJ, Allen PM. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med 1996; 184:1259-68; PMID:8879197; http://dx.doi.org/10.1084/jem.184.4.1259.
3. Donermeyer DL, Weber KS, Kranz DM, Allen PM. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. J Immunol 2006; 177:6911-9; PMID:17082606.
4. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006; 24:419-66; PMID:16551255; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115658.
5. De Groot AS, Bosma A, Chinai N, Frost J, Jesdale BM, Gonzalez MA, et al. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 2001; 19:4385-95; PMID:11483263; http://dx.doi.org/10.1016/S0264-410X(01)00145- 1.
6. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998; 19:395-404; PMID:9745202; http://dx.doi.org/10.1016/S0167-5699(98)01299-7.
7. Colf LA, Bankovich AJ, Hanick NA, Bowerman NA, Jones LL, Kranz DM, et al. How a single T cell receptor recognizes both self and foreign MHC. Cell 2007; 129:135-46; PMID:17418792; http://dx.doi.org/10.1016/j.cell.2007.01.048.
8. Deshmukh US, Sim DL, Dai C, Kannapell CJ, Gaskin F, Rajagopalan G, et al. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. J Autoimmun 2011; 37:254-62; PMID:21868195; http://dx.doi.org/10.1016/j.jaut.2011.07.002.
9. Borbulevych OY, Piepenbrink KH, Baker BM. Conformational melding permits a conserved binding geometry in TCR recognition of foreign and self molecular mimics. J Immunol 2011; 186:2950-8; PMID:21282516; http://dx.doi.org/10.4049/ jimmunol.1003150.
10. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010; 184:2204-10; PMID:20083660; http://dx.doi.org/10.4049/jimmunol.0900709.
11. Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, Luzuriaga K, et al. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 2005; 115:3602-12; PMID:16308574; http://dx.doi.org/10.1172/ JCI25078.
12. Bashyam HS, Green S, Rothman AL. Dengue virusreactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006; 176:2817-24; PMID:16493038.
13. Chen HD, Fraire AE, Joris I, Brehm MA, Welsh RM, Selin LK. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2001; 2:1067-76; PMID:11668342; http://dx.doi.org/10.1038/ni727.
14. Welsh RM, Fujinami RS. Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 2007; 5:555-63; PMID:17558423; http://dx.doi.org/10.1038/nrmicro1709.
15. Selin LK, Wlodarczyk MF, Kraft AR, Nie S, Kenney LL, Puzone R, et al. Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity 2011; 44:328-47; PMID:21250837; http://dx.doi.org/10. 3109/08916934.2011.523277.
16. Welsh RM, Che JW, Brehm MA, Selin LK. Heterologous immunity between viruses. Immunol Rev 2010; 235:244-66; PMID:20536568.
17. Page KR, Scott AL, Manabe YC. The expanding realm of heterologous immunity: friend or foe? Cell Microbiol 2006; 8:185-96; PMID:16441430; http://dx.doi.org/10.1111/j.1462-5822.2005.00653.x.
18. Santiago HC, LeeVan E, Bennuru S, Ribeiro-Gomes F, Mueller E, Wilson M, et al. Molecular mimicry between cockroach and helminth glutathione S-transferases promotes cross-reactivity and cross-sensitization. J Allergy Clin Immunol 2012; 130:248-56.e9.
19. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. NatMed 2003; 9:921-7; PMID:12808447; http://dx.doi.org/10.1038/nm887.
20. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol 2006; 176:3821-9; PMID:16517753.
21. Nie S, Lin SJ, Kim SK, Welsh RM, Selin LK. Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. Am J Pathol 2010; 176:2107-12; PMID:20348239; http://dx.doi.org/10. 2353/ajpath.2010.090656.
22. de St Groth BF. Regulatory T-cell abnormalities and the global epidemic of immuno-inflammatory disease. Immunol Cell Biol 2012; 90:256-9; PMID:22310378; http://dx.doi.org/10.1038/icb.2011.113.
23. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538-41; PMID:22031325; http://dx.doi.org/10. 1038/nature10554.
24. Ng SC, Benjamin JL, McCarthy NE, Hedin CR, Koutsoumpas A, Plamondon S, et al. Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease. Inflamm Bowel Dis 2011; 17:2027-37; PMID:21910165; http://dx.doi.org/10.1002/ibd.21590.
25. Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C, et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One 2012; 7:e49138; PMID:23209564; http://dx.doi.org/10.1371/journal.pone.0049138.
26. McLoughlin RM, Mills KH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 2011; 127:1097-107, quiz 1108-9; PMID:21420159; http://dx.doi.org/10.1016/j. jaci.2011.02.012.
27. Gaboriau-Routhiau V, Lécuyer E, Cerf-Bensussan N. Role of microbiota in postnatal maturation of intestinal T-cell responses. Curr Opin Gastroenterol 2011; 27:502-8; PMID:21946030; http://dx.doi.org/10.1097/MOG. 0b013e32834bb82b.
28. Pils MC, Bleich A, Prinz I, Fasnacht N, Bollati- Fogolin M, Schippers A, et al. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-10. Inflamm Bowel Dis 2011; 17:2038-46; PMID:21182023; http://dx.doi.org/10.1002/ibd.21587.
29. Dahlqvist G, Piessevaux H. Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets. Acta Gastroenterol Belg 2011; 74:375-80; PMID:22103040.
30. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012; 149:1578-93; PMID:22726443; http://dx.doi.org/10.1016/j.cell.2012.04.037.
31. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330:1768-73; PMID:21205662; http://dx.doi.org/10.1126/science.1195568.
32. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478:250-4; PMID:21937990; http://dx.doi.org/10.1038/nature10434.
33. Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, Halfvarson J, et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 2009; 3:179-89; PMID:18971961; http://dx.doi.org/10.1038/ismej.2008.108.
34. Lee LH, Corrier K, Dill B, Shah M, Hettich R, Jansson J, et al. Advanced deep metaproteomics methods provide unique insights into the diversity of the human proteome and gut microbiota in healthy adults. Advanced deep metaproteomics methods provideunique insights into the diversity of the human proteome and gut microbiota in healthy adults. In: 61st American Society for Mass Spectrometry (ASMS) Conference, June 9-13, 2013, Minneapolis, MN.
35. Losikoff PT, Self AA, Gregory SH. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. Virulence 2012; 3:610-20; PMID:23076334; http://dx.doi.org/10.4161/viru.21823.
36. Self AA, Losikoff PT, Gregory SH, Regulatory T. Cells Promote the Pathogenesis of Chronic Hepatitis C. Hum Vaccin Immunother (Manuscript submitted).
37. +regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection. PLoS Pathog 2009; 5:e1000707; PMID:20041222; http://dx.doi.org/10.1371/journal.ppat.1000707.
38. Newell EW, Klein LO, Yu W, Davis MM. Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Methods 2009; 6:497-9; PMID:19543286; http://dx.doi.org/10.1038/nmeth.1344.
39. Weber CA, Mehta PJ, Ardito M, Moise L, Martin B, De Groot AS. T cell epitope: friend or foe? Immunogenicity of biologics in context. Adv Drug Deliv Rev 2009; 61:965-76; PMID:19619593; http://dx.doi.org/10.1016/j.addr.2009.07. 001.
40. De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, et al. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood 2008; 112:3303-11; PMID:18660382; http://dx.doi.org/10.1182/blood-2008-02-138073.
41. Wei R, Yang C, Zeng M, Terry F, Zhu K, Yang C, et al. A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses. PLoS One 2012; 7:e51957; PMID:23251663; http://dx.doi.org/10.1371/journal.pone. 0051957.
42. Moss SF, Moise L, Lee DS, Kim W, Zhang S, Lee J, et al. HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer. Vaccine 2011; 29:2085-91; PMID:21236233; http://dx.doi.org/10.1016/j. vaccine.2010.12.130.
43. Schanen BC, De Groot AS, Moise L, Ardito M, McClaine E, Martin WB, et al. Coupling sensitive in vitro and in silico techniques to assess crossreactive CD4(+) T cells against the swine-origin H1N1 influenza virus. Vaccine 2011; 29:3299-309; PMID:21349362; http://dx.doi.org/10.1016/j.vaccine.2011.02.019.
44. Trost B, Kusalik A, Lucchese G, Kanduc D. Bacterial peptides are intensively present throughout the human proteome. Self Nonself 2010; 1:71-4; PMID:21559180; http://dx.doi.org/10.4161/self.1.1.9588.
45. Rist M, Smith C, Bell MJ, Burrows SR, Khanna R. Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood 2009; 114:2244-53; PMID:19617574; http://dx.doi.org/10.1182/blood-2009-05-222596.
46. Takahashi Y, Matsuda K, Kubota Y, Shimomura J, Yamasaki E, Kudo T, et al. Vaccination and infection as causative factors in Japanese patients with Rasmussen syndrome: molecular mimicry and HLA class I. Clin Dev Immunol 2006; 13:381-7; PMID:17162382; http://dx.doi.org/10.1080/17402520600589522.
47. de Carvalho JF, Shoenfeld Y. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. Eur J Intern Med 2008; 19:383-5; PMID:18549949; http://dx.doi.org/10.1016/j.ejim.2007.10.005.
48. Israeli E, Agmon-Levin N, Blank M, Chapman J, Shoenfeld Y. Guillain-Barré syndrome-a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012; 42:121-30; PMID:20890797; http://dx.doi.org/10.1007/s12016-010-8213-3.
49. Kennedy JS, Co M, Green S, Longtine K, Longtine J, O'Neill MA, et al. The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers. Vaccine 2008; 26:4420-4; PMID:18588934; http://dx.doi.org/10.1016/j.vaccine.2008.05.090.
50. Morgan J, Roper MH, Sperling L, Schieber RA, Heffelfinger JD, Casey CG, et al. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003. Clin Infect Dis 2008; 46(Suppl 3):S242-50; PMID:18284365; http://dx.doi.org/10.1086/ 524747.
51. Orbach H, Agmon-Levin N, Zandman-Goddard G. Vaccines and autoimmune diseases of the adult. Discov Med 2010; 9:90-7; PMID:20193633.
52. Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, et al. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine 2011; 29:886-9; PMID:20869467; http://dx.doi.org/10.1016/j.vaccine.2010.09.020.
53. Kim SK, Cornberg M, Wang XZ, Chen HD, Selin LK, Welsh RM. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J Exp Med 2005; 201:523-33; PMID:15710651; http://dx.doi.org/10.1084/jem. 20041337.
54. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006; 24:419-66; PMID:16551255; http://dx.doi.org/10.1146/annurev.immunol.23.021704.115658.
55. Rammensee HG. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 1995; 7:85-96; PMID:7772286; http://dx.doi.org/10.1016/0952-7915(95)80033-6.
56. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 1995; 13:587-622; PMID:7612235; http://dx.doi.org/10.1146/annurev. iy.13.040195.003103
57. UniProt Consortium. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 2012; 40(Database issue):D71-5; PMID:22102590; http://dx.doi.org/10.1093/nar/gkr981.
58. Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol 2012; 10:e1001377; PMID:22904687; http://dx.doi.org/10. 1371/journal.pbio.1001377.
59. Calis JJ, de Boer RJ, Keşmir C. Degenerate T-cell recognition of peptides on MHC molecules creates large holes in the T-cell repertoire. PLoS Comput Biol 2012; 8:e1002412; PMID:22396638; http://dx.doi.org/10.1371/journal. pcbi.1002412.
60. Hertz T, Nolan D, James I, John M, Gaudieri S, Phillips E, et al. Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 2011; 85:1310-21; PMID:21084470; http://dx.doi.org/10.1128/JVI.01966-10.
61. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498-504; PMID:14597658; http://dx.doi.org/10.1101/gr.1239303.
62. De Groot AS, Martin W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol 2009; 131:189-201; PMID:19269256; http://dx.doi.org/10.1016/j.clim.2009.01.009.